Concomitant csDMARDs With bDMARDs Reduces Discontination Rates in RA - Rheumatology Advisor

Concomitant csDMARDs With bDMARDs Reduces Discontination Rates in RA  Rheumatology Advisor

Researchers in Canada found data that showed in patients with rheumatoid arthritis, biologic disease-modifying antirheumatic drugs (bDMARDs) and ...